» Articles » PMID: 15349768

Telomerase RNA Deficiency in Peripheral Blood Mononuclear Cells in X-linked Dyskeratosis Congenita

Overview
Journal Hum Genet
Specialty Genetics
Date 2004 Sep 7
PMID 15349768
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Compromised renewal and eventual failure of the hematopoietic system in dyskeratosis congenita (DC) have been proposed to arise from a deficiency in telomerase function. Previously, cultured cell lines from patients with X-linked DC were shown to accumulate less telomerase RNA than cell lines from unaffected family members. Here, we report that telomerase RNA deficiency is also present in the circulating lymphocytes of DC patients. We have compared the accumulation levels of telomerase RNA and a panel of other small RNAs in peripheral blood mononuclear cells from an X-linked DC patient and an unaffected maternal carrier and similarly analyzed cultured lymphoblasts from an X-linked DC patient and maternal carrier in a second family. The DC-patient lymphoid cells show a specific defect in telomerase RNA accumulation with or without cell culture. Our findings support the clinical significance of telomerase deficiency and encourage the use of telomerase activation as a disease therapy.

Citing Articles

2.7 Å cryo-EM structure of human telomerase H/ACA ribonucleoprotein.

Ghanim G, Sekne Z, Balch S, van Roon A, Nguyen T Nat Commun. 2024; 15(1):746.

PMID: 38272871 PMC: 10811338. DOI: 10.1038/s41467-024-45002-x.


A missense variant in the nuclear localization signal of DKC1 causes Hoyeraal-Hreidarsson syndrome.

Chu C, Yu H, Kao T, Chen Y, Lu H, Wu E NPJ Genom Med. 2022; 7(1):64.

PMID: 36309505 PMC: 9617742. DOI: 10.1038/s41525-022-00335-8.


A novel cause of -related bone marrow failure: Partial deletion of the 3' untranslated region.

Arthur J, Pickett H, Barbaro P, Kilo T, Vasireddy R, Beilharz T EJHaem. 2022; 2(2):157-166.

PMID: 35845273 PMC: 9175968. DOI: 10.1002/jha2.165.


Case Report: A Missense Mutation in Dyskeratosis Congenita 1 Leads to a Benign Form of Dyskeratosis Congenita Syndrome With the Mucocutaneous Triad.

Wang L, Li J, Xiong Q, Zhou Y, Li P, Wu C Front Pediatr. 2022; 10:834268.

PMID: 35463902 PMC: 9019361. DOI: 10.3389/fped.2022.834268.


N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.

MacNeil D, Lambert-Lanteigne P, Autexier C Nucleic Acids Res. 2019; 47(10):5368-5380.

PMID: 30931479 PMC: 6547437. DOI: 10.1093/nar/gkz233.


References
1.
Blasco M, Hahn W . Evolving views of telomerase and cancer. Trends Cell Biol. 2003; 13(6):289-94. DOI: 10.1016/s0962-8924(03)00085-0. View

2.
Montanaro L, Chilla A, Trere D, Pession A, Govoni M, Tazzari P . Increased mortality rate and not impaired ribosomal biogenesis is responsible for proliferative defect in dyskeratosis congenita cell lines. J Invest Dermatol. 2002; 118(1):193-8. DOI: 10.1046/j.0022-202x.2001.01634.x. View

3.
Fogarty P, Yamaguchi H, Wiestner A, Baerlocher G, Sloand E, Zeng W . Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet. 2003; 362(9396):1628-30. DOI: 10.1016/S0140-6736(03)14797-6. View

4.
Filipowicz W, Pelczar P, Pogacic V, Dragon F . Structure and biogenesis of small nucleolar RNAs acting as guides for ribosomal RNA modification. Acta Biochim Pol. 1999; 46(2):377-89. View

5.
Harrington L . Biochemical aspects of telomerase function. Cancer Lett. 2003; 194(2):139-54. DOI: 10.1016/s0304-3835(02)00701-2. View